52 results
6-K
EX-10.2
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
in good faith by the Parent Board.
3.Compensation and Benefits. The Company shall pay or provide, as the case may be, to Executive the compensation … and other benefits and rights set forth in this Section 3.
(a)Base Salary. The Company shall pay to Executive an initial base salary of $650,000 per year
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
(each as defined in his employment agreement), he is entitled to the following payments and benefits, subject (except as provided below) to his timely … of the benefits described above, Dr. Quart is entitled to the following payments and benefits, subject to his timely execution and non-revocation
6-K
EX-10.1
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
or enlargement of the benefits or potential benefits intended by the Company to be made available under the Plan or with respect to any Award granted … or a Related Entity, Awards shall not be deemed compensation for purposes of computing benefits or contributions under any retirement plan
6-K
EX-10.3
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
duties to the Company, as determined in good faith by the Chief Executive Officer or the Parent Board.
3.Compensation and Benefits. The Company shall … pay or provide, as the case may be, to Executive the compensation and other benefits and rights set forth in this Section 3.
(a)Base Salary
6-K
EX-99.1
4v27c8 khjv
23 Jun 23
House Lease Contract
4:31pm
6-K
EX-99.1
xebsm56u4r1
5 Jun 23
Current report (foreign)
4:28pm
F-3/A
z3g24b
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
6-K
EX-99.1
jbilp1 ox93a
10 Jun 22
Current report (foreign)
6:05am
F-3/A
rgoy42p
20 May 22
Shelf registration (foreign) (amended)
6:54pm
6-K
EX-99.2
799bvorff3w
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
F-3
EX-1.2
z55mmgd1w3pipuh
15 Apr 22
Shelf registration (foreign)
5:27pm
F-3
gnmq7lm8d xqx7f9te
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
EX-4.12
6q2plq
31 Mar 22
Annual report (foreign)
4:33pm
20-F
9xt8cgrhj
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.10
8dc7m5l1mg48a9
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.13
esod9czr5vfzgds
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.11
u5p90nxi5qtgor
31 Mar 22
Annual report (foreign)
4:33pm